CHICAGO–(BUSINESS WIRE)–SimBioSys, a TechBio company unlocking the power of spatial biophysics with artificial intelligence (AI) and data science to redefine precision medicine for cancer...
Pharma giant AstraZeneca has signed a $247 million deal with Ai drug creation company Absci to develop an antibody designed to fight cancer.
The collaboration...
The Company announces a new identity for its iBiopsy® AI/ML tech-based suite of software as medical devices (SaMD), and business unit.
iBiopsy® becomes eyonis™.
eyonis™ brand...
AI Theater Presentation: “Transforming Cancer Diagnosis through End-to-End AI-Powered SaMD”
Median’s teams will be at booth #4465, South Hall Level 3, to present the latest...
MINNEAPOLIS–(BUSINESS WIRE)–Flywheel, a leading medical imaging artificial intelligence (AI) development platform, today announced the launch of its software-as-a-service (SaaS) data management solution on Microsoft...
This is a joint blog with AWS and Philips. Philips is a health technology company focused on improving people’s lives through meaningful innovation. Since...
IntroductionMore than 150 years ago, the economist and philosopher William Stanley Jevons discovered something curious about the number 4. While musing about how the...